CURE: a phase-based therapeutic framework for chronic inflammation - Top-Institutions - MDSpire

CURE: a phase-based therapeutic framework for chronic inflammation

  • By

  • Nils Kurzen

  • Stefan Weißinger

  • Hjalmar Kurzen

  • June 15, 2026

  • 0 min

Share

Top Institutions in Rheumatology

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, Maryland

    Key Differentiators

    • Rheumatology

  • #2

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, Ohio

    Key Differentiators

    • Rheumatology
    • Immunology

  • #3

    Temple
    Temple

    Philadelphia, Pennsylvania

    Key Differentiators

    • Rheumatology

Original Source(s)

CURE: a phase-based therapeutic framework for chronic inflammation

  • by Nils Kurzen, Stefan Weißinger, Hjalmar Kurzen

  • June 15, 2026

Related Content

Combination Therapy Shows Potential in Psoriasis, Obesity

Researchers assess whether adding tirzepatide to ixekizumab affects skin and weight outcomes in adults with moderate to severe plaque psoriasis.

Risankizumab versus Deucravacitinib in Adults With Moderate Plaque Psoriasis: 16-Week Results from the Phase 4 IMMpactful Trial

Coordinated Care Strategies for Psoriasis: An Organized Method for Timely Identification and Referral of Comorbid Conditions